HPGD and sarcopenia: Palla et al. showed that inhibition of 15-PGDH increased aged muscle mass, strength, and exercise performance, suggesting that 15-PGDH may become a potential therapeutic target in future to counter the debilitating muscle atrophy characteristic of sarcopenia [10].